Displaying all 2 publications

Abstract:
Sort:
  1. Fulltext Establishment and analysis of the 3-dimensional (3D) spheroids generated from the Nasopharyngeal Carcinoma cell line HK1
    Muniandy, Kalaivani, Sankar, Prabu Siva, Lian, Benedict Shi Xiang, Khoo, Alan Soo-Beng, Balakrishnan, Venugopal, Mohana-Kumaran, Nethia
    Trop Life Sci Res, 2016;27(11):125-130.
    MyJurnal
    Spheroids have been shown to recapitulate the tumour in vivo with properties
    such as the tumour microenvironment, concentration gradients, and tumour phenotype. As
    such, it can serve as a platform for determining the growth and invasion behaviour pattern
    of the cancer cells as well as be utilised for drug sensitivity assays; capable of exhibiting
    results that are closer to what is observed in vivo compared to two-dimensional (2D) cell
    culture assays. This study focused on establishing a three-dimensional (3D) cell culture
    model using the Nasopharyngeal Carcinoma (NPC) cell line, HK1 and analysing its growth
    and invasion phenotypes. The spheroids will also serve as a model to elucidate their
    sensitivity to the chemotherapeutic drug, Flavopiridol. The liquid overlay method was
    employed to generate the spheroids which was embedded in bovine collagen I matrix for
    growth and invasion phenotypes observation. The HK1 cells formed compact spheroids
    within 72 hours. Our observation from the 3 days experiments revealed that the spheroids
    gradually grew and invaded into the collagen matrix, showing that the HK1 spheroids are
    capable of growth and invasion. Progressing from these experiments, the HK1 spheroids
    were employed to perform a drug sensitivity assay using the chemotherapeutic drug,
    Flavopiridol. The drug had a dose-dependent inhibition on spheroid growth and invasion.
  2. Fulltext Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines
    Lian BSX, Yek AEH, Shuvas H, Abdul Rahman SF, Muniandy K, Mohana-Kumaran N
    BMC Res Notes, 2018 Mar 27;11(1):197.
    PMID: 29580266 DOI: 10.1186/s13104-018-3302-0
    OBJECTIVE: There are number of studies which report that BCL-2 anti-apoptotic proteins (e.g. BCL-2, BCL-XL, and MCL-1) are highly expressed in cervical cancer tissues compared to the normal cervical epithelia. Despite these reports, targeting these proteins for cervical cancer treatment has not been explored extensively. BH3-mimetics that inhibit specific BCL-2 anti-apoptotic proteins may hold encouraging treatment outcomes for cervical cancer management. Hence, the aim of this pilot study is to investigate the sensitivity of cervical cancer cell lines to combination of two BH3-mimetics namely ABT-263 which selectively inhibits BCL-2, BCL-XL and BCL-w and A-1210477, a selective MCL-1 inhibitor.

    RESULTS: We report that combination of A-1210477 and ABT-263 exhibited synergistic effects on all cervical cancer cell lines tested. Drug sensitization studies revealed that A-1210477 sensitised the cervical cancer cell lines SiHa and CaSki to ABT-263 by 11- and fivefold, respectively. Sensitization also occurred in the opposite direction whereby ABT-263 sensitised SiHa and CaSki to A-1210477 by eightfold. This report shows that combination of ABT-263 and A-1210477 could be a potential treatment strategy for cervical cancer. Extensive drug mechanistic studies and drug sensitivity studies in physiological models are necessary to unleash the prospect of this combination for cervical cancer therapy.

Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links